Gregory Henderson

Areas of Expertise

• Lipid metabolism, Obesity, Diabetes, Nutrition Science, Exercise

HHS Signature Research Area(s)

• Healthy Lifestyles and Vital Longevity

Department of Nutrition Science Research Area(s)

• Metabolism and Obesity

Biography

Greg Henderson received a BA and PhD in Integrative Biology from the University of California, Berkeley, followed by postdoctoral training in Endocrinology at the Mayo Clinic.  He is now a faculty member in the department of Nutrition Science at Purdue.  Dr. Henderson teaches coursework related to nutrition science, physiology, and metabolism.  His research lab studies lipid metabolism in mouse models in relation to type 2 diabetes and insulin resistance.  Specifically the team focuses upon the relationship between plasma free fatty acid trafficking, hepatic lipid accumulation, and glucose metabolism.  Metabolism and physiology is tested in live mice, followed by molecular biology and analytical chemistry based measurements on tissues.  The work is aimed at discovering how altering the transfer of free fatty acids between tissues can alter metabolic health.

Education

• PhD, 2007, University of California, Berkeley

Current Courses

• NUTR 105 - Nutrition in the 21st Century - Nutrition Issues for Practice and Research
• NUTR 496 - Evaluation of Nutrition Science Research
• NUTR 606 - Nutritional Biochemistry and Physiology II - Nutrient Metabolism and its Regulation

Selected Grants

• Principal Investigator, Plasma free fatty acids and albumin in metabolic disease, NIH: National Institute of Diabetes and Digestive and Kidney Diseases (1R56DK128008-01A1). Gregory C. Henderson (PI). Period 9/1/2021 – 8/31/2022. Total: $125,000
• Principal Investigator, Targeting plasma free fatty acids through a novel approach as a potential intervention for insulin resistance, Pilot and Feasibility Award within NIH Grant P30 DK097512. Gregory C. Henderson (PI). Period 7/1/2021 – 6/30/2022. Total: $50,000
• Principal Investigator, Altering lipid metabolism to improve insulin sensitivity: impaired exercise capacity as a potential side effect, Ralph W. and Grace M. Showalter Research Trust. Gregory C. Henderson (PI). Period 7/1/2021 – 7/31/2022. Total: $75,000